2.3(top 20%)
impact factor
1.0K(top 20%)
papers
19.6K(top 10%)
citations
61(top 10%)
h-index
2.4(top 20%)
impact factor
1.2K
all documents
20.9K
doc citations
90(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometryCytometry Part B - Clinical Cytometry2005277
2Human peripheral blood B‐cell compartments: A crossroad in B‐cell trafficCytometry Part B - Clinical Cytometry2010258
3CD38 and CD157: A long journey from activation markers to multifunctional moleculesCytometry Part B - Clinical Cytometry2013236
4Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometryCytometry Part B - Clinical Cytometry2010195
52006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasiaCytometry Part B - Clinical Cytometry2007194
6Considerations for the control of background fluorescence in clinical flow cytometryCytometry Part B - Clinical Cytometry2009190
7Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry dataCytometry Part B - Clinical Cytometry2010178
8Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myelomaCytometry Part B - Clinical Cytometry2016177
9Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrowCytometry Part B - Clinical Cytometry2006155
10Flowcytometric phenotyping of common variable immunodeficiencyCytometry Part B - Clinical Cytometry2008155
11Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteriaCytometry Part B - Clinical Cytometry2013153
12Basophil activation test by flow cytometry: Present and future applications in allergologyCytometry Part B - Clinical Cytometry2008149
13Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reportingCytometry Part B - Clinical Cytometry2016144
14Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation projectCytometry Part B - Clinical Cytometry2018133
15Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasibleCytometry Part B - Clinical Cytometry2008132
16B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral bloodCytometry Part B - Clinical Cytometry2010126
17Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometryCytometry Part B - Clinical Cytometry2016118
18Comparison of two methods for enumerating circulating tumor cells in carcinoma patientsCytometry Part B - Clinical Cytometry2005113
19Kinetics of H2AX phosphorylation after exposure to cisplatinCytometry Part B - Clinical Cytometry2009113
20Practical guidelines for the high‐sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometryCytometry Part B - Clinical Cytometry2012112
21Markers and function of human NK cells in normal and pathological conditionsCytometry Part B - Clinical Cytometry2017110
22Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell‐related disordersCytometry Part B - Clinical Cytometry2010109
23Flow cytometric characterization of cerebrospinal fluid cellsCytometry Part B - Clinical Cytometry2011108
24Consensus guidelines for myeloma minimal residual disease sample staining and data acquisitionCytometry Part B - Clinical Cytometry2016108
25Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part III – analytical issuesCytometry Part B - Clinical Cytometry2013101
26Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuriaCytometry Part B - Clinical Cytometry200697
27External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility studyCytometry Part B - Clinical Cytometry201197
28AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic LeukemiaCytometry Part B - Clinical Cytometry201896
292006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indicationsCytometry Part B - Clinical Cytometry200795
30Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levelsCytometry Part B - Clinical Cytometry200593
31Detection of minimal residual disease in pediatric acute lymphoblastic leukemiaCytometry Part B - Clinical Cytometry201392
32Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routineCytometry Part B - Clinical Cytometry200790
33Single cell analysis of human tissues and solid tumors with mass cytometryCytometry Part B - Clinical Cytometry201789
34A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCsCytometry Part B - Clinical Cytometry200988
35Indirect immunofluorescence in autoimmune diseases: Assessment of digital images for diagnostic purposeCytometry Part B - Clinical Cytometry200787
36Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)Cytometry Part B - Clinical Cytometry201086
37An image analysis approach for automatic malignancy determination of prostate pathological imagesCytometry Part B - Clinical Cytometry200785
38A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapyCytometry Part B - Clinical Cytometry201884
39Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology groupCytometry Part B - Clinical Cytometry200582
40Diagnosing PNH with FLAER and multiparameter flow cytometryCytometry Part B - Clinical Cytometry200782
41CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotypingCytometry Part B - Clinical Cytometry201982
42Normalization of bone marrow aspirates for hemodilution in flow cytometric analysesCytometry Part B - Clinical Cytometry200981
43Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapyCytometry Part B - Clinical Cytometry200780
44Extended immunophenotyping reference values in a healthy pediatric populationCytometry Part B - Clinical Cytometry201979
45Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervixCytometry Part B - Clinical Cytometry200678
46Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samplesCytometry Part B - Clinical Cytometry201378
47Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringCytometry Part B - Clinical Cytometry200577
48CD203c‐based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulationCytometry Part B - Clinical Cytometry201077
49Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergyCytometry Part B - Clinical Cytometry200576
50Sepsis‐induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapyCytometry Part B - Clinical Cytometry201676